Grant of Options

Inspiration Healthcare Group PLC
09 June 2023
 

9 June 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Grant of Options

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that it has granted a total of 573,539 nil cost options over ordinary shares of 10 pence each in the capital of the Company ("Options") under the Inspiration Healthcare Group Long Term Incentive Plan (the "LTIP"), including a total of 417,970 Options to four Persons Discharging Managerial Responsibilities ("PDMRs") as detailed below.

The Options are exercisable at nil cost and are subject to operational performance criteria measured over a three year period ending on 31 January 2026.

 

For further information:

Inspiration Healthcare Group plc

                        Tel: +44 (0)330 175 0000

Neil Campbell, Chief Executive Officer




Liberum (Nominated Adviser & Broker)

                        Tel: +44 (0)20 3100 2000

Phil Walker, Richard Lindley, William Hall, Will King


 


Walbrook PR Ltd (Media and Investor Relations)

                        Tel: +44 (0)20 7933 8780

Anna Dunphy/Stephanie Cuthbert



 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1.  Neil Campbell

2.  Brook Nolson

3.  Martin Pearcy

4.  Peter Reynolds

2

Reason for the notification

a)

Position/status

1.  PDMR (CEO)

2.  PDMR (COO)

3.  PDMR

4.  PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Inspiration Healthcare Group plc

 

b)

LEI

213800GKFT3ENAPMDL15

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares of 10p each in the capital of the Company

ISIN: GB00BXDZL105

b)

Nature of the transaction

Grant of Options under the Long Term Incentive Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

1. Nil

2. Nil

3. Nil

4. Nil

1. 155,043

2. 124,034

3. 87,212

4. 51,681



 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

 
N/A - single transaction

 

e)

Date of the transaction

8 June 2023

f) 

Place of the transaction

Outside of a trading venue

 


About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products.  The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products.  This is supported by Technical Support for planned preventative maintenance and emergency assistance.

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex).  The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings